|
Successful patent challenger
|
= 1 if a generic manufacturer, from 2015 to 2019, granted a marketing approval with 9-month exclusivity after challenging a patent and obtaining favorable decision at a court
|
|
Aggressive patent challenger
|
= 1 if a generic manufacturer, from 2015 to 2019, achieved 4 and more successful patent challenges
|
|
Innovative
|
= 1 if a generic manufacturer designated as innovative pharmaceutical manufacturers by the ministry of health as of 2019
|
|
New drug
|
= 1 if a generic manufacturer granted a marketing approval for new drug or modified new drug as of 2019
|
|
Sales
|
Total sales of a manufacturer in 2019 (million Korean Won)
|
|
Employees
|
Total employees of a manufacturer in 2019 (full time employees)
|
|
Reimbursed drugs
|
Total number of reimbursed drugs under the National Health Insurance that a manufacturer granted marketing approval as of 2019
|
